Rachel Giblon

1.5k total citations · 1 hit paper
39 papers, 898 citations indexed

About

Rachel Giblon is a scholar working on Rheumatology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rachel Giblon has authored 39 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 7 papers in General Health Professions and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rachel Giblon's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Smoking Behavior and Cessation (3 papers). Rachel Giblon is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Smoking Behavior and Cessation (3 papers). Rachel Giblon collaborates with scholars based in United States, Canada and France. Rachel Giblon's co-authors include Greta R. Bauer, Nilay D. Shah, Rozalina G. McCoy, Jonathan Inselman, Shaheen Kurani, Michelle A. Lampman, David Rushlow, Lila J. Finney Rutten, Sagar Chawla and Cynthia S. Crowson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rachel Giblon

34 papers receiving 890 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial

2022 135 citations Peter A. Noseworthy, Zachi I. Attia et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Giblon United States	14	150	143	142	138	136	39	898
Hui‐Chu Lang Taiwan	19	85 0.6×	231 1.6×	80 0.6×	56 0.4×	184 1.4×	44	1.5k
David J. Tunnicliffe Australia	18	323 2.2×	129 0.9×	120 0.8×	74 0.5×	26 0.2×	69	1.2k
Montserrat Roset Spain	17	116 0.8×	237 1.7×	81 0.6×	18 0.1×	210 1.5×	50	1.3k
Álvaro Hidalgo‐Vega Spain	17	80 0.5×	115 0.8×	100 0.7×	14 0.1×	99 0.7×	81	824
Kate Khair United Kingdom	29	56 0.4×	108 0.8×	115 0.8×	18 0.1×	76 0.6×	152	2.6k
Chonghua Wan China	17	29 0.2×	141 1.0×	52 0.4×	58 0.4×	362 2.7×	91	938
Warren Fong Singapore	21	538 3.6×	205 1.4×	47 0.3×	28 0.2×	70 0.5×	116	1.4k
Kostas Athanasakis Greece	15	52 0.3×	179 1.3×	91 0.6×	19 0.1×	55 0.4×	132	808
Mohsen Gadallah Egypt	17	50 0.3×	78 0.5×	38 0.3×	59 0.4×	64 0.5×	61	785
Stefano Capri Italy	17	46 0.3×	74 0.5×	43 0.3×	19 0.1×	127 0.9×	67	938

Countries citing papers authored by Rachel Giblon

Since Specialization

Citations

This map shows the geographic impact of Rachel Giblon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Giblon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Giblon more than expected).

Fields of papers citing papers by Rachel Giblon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Giblon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Giblon. The network helps show where Rachel Giblon may publish in the future.

Co-authorship network of co-authors of Rachel Giblon

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Giblon. A scholar is included among the top collaborators of Rachel Giblon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Giblon. Rachel Giblon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giblon, Rachel, Alyson Mahar, Julie Hallet, et al.. (2025). Intellectual and developmental disabilities (IDD) and cancer symptom reporting: a matched retrospective cohort study. Supportive Care in Cancer. 33(7). 571–571.

Boehmer, Kasey R., Megan E. Branda, Rachel Giblon, et al.. (2024). Care for patients living with chronic conditions using the ICAN Discussion Aid: A mixed methods cluster-randomized trial. PLoS ONE. 19(12). e0314605–e0314605.

Giblon, Rachel, Sara J. Achenbach, Elena Myasoedova, et al.. (2024). Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study. The Journal of Rheumatology. 52(3). 210–218.

Giblon, Rachel, et al.. (2023). The Incidence and Outcomes of Breast Implants Among 1696 Women over more than 50 Years. Aesthetic Plastic Surgery. 47(6). 2268–2276. 3 indexed citations

Giblon, Rachel, Alanna M. Chamberlain, Christi A. Patten, et al.. (2022). Indigenous Smoking Behaviors in Olmsted County, Minnesota. Mayo Clinic Proceedings. 97(10). 1836–1848. 3 indexed citations

Koster, Matthew J., Cynthia S. Crowson, Rachel Giblon, et al.. (2022). Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study. Annals of the Rheumatic Diseases. 81(6). 861–867. 56 indexed citations

Noseworthy, Peter A., Zachi I. Attia, Emma Behnken, et al.. (2022). Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial. The Lancet. 400(10359). 1206–1212. 135 indexed citations breakdown →

Thorsteinsdottir, Björg, LaTonya J. Hickson, Rachel Giblon, et al.. (2021). Validation of prognostic indices for short term mortality in an incident dialysis population of older adults >75. PLoS ONE. 16(1). e0244081–e0244081. 4 indexed citations

Lampman, Michelle A., Aravind Chandrasekaran, Megan E. Branda, et al.. (2021). Optimizing Huddle Engagement Through Leadership and Problem Solving Within Primary Care: Results from a Cluster-Randomized Trial. Journal of General Internal Medicine. 36(8). 2292–2299. 5 indexed citations

10.

Genere, Natalia, Rachel Giblon, Salvatore Vaccarella, et al.. (2021). Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century. Mayo Clinic Proceedings. 96(11). 2823–2830. 12 indexed citations

11.

Chamberlain, Alanna M., et al.. (2021). Tobacco Prevalence, Incidence, Relapse, and Cessation in Native Americans. A1647–A1647. 2 indexed citations

12.

Myasoedova, Elena, et al.. (2021). Body mass index trend and variability in rheumatoid arthritis. Clinical Rheumatology. 41(2). 349–355. 3 indexed citations

13.

Myasoedova, Elena, John M. Davis, Vanessa L. Kronzer, et al.. (2021). The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study. Seminars in Arthritis and Rheumatism. 52. 151941–151941. 4 indexed citations

14.

Myasoedova, Elena, et al.. (2020). THU0091 BODY MASS INDEX TRAJECTORY IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 79. 258–259. 2 indexed citations

15.

Kurani, Shaheen, Rozalina G. McCoy, Jonathan Inselman, et al.. (2020). Place, poverty and prescriptions: a cross-sectional study using Area Deprivation Index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017. BMJ Open. 10(5). e035376–e035376. 47 indexed citations

16.

Kurani, Shaheen, Rozalina G. McCoy, Michelle A. Lampman, et al.. (2020). Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest. JAMA Network Open. 3(3). e200618–e200618. 194 indexed citations

17.

Spencer‐Bonilla, Gabriela, Oscar J. Ponce, Marleen Kunneman, et al.. (2020). Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study. Trials. 21(1). 395–395. 11 indexed citations

18.

Boehmer, Kasey R., Claudia C. Dobler, Megan E. Branda, et al.. (2019). Changing conversations in primary care for patients living with chronic conditions: pilot and feasibility study of the ICAN Discussion Aid. BMJ Open. 9(9). e029105–e029105. 22 indexed citations

19.

Branda, Megan E., Aravind Chandrasekaran, Nilay D. Shah, et al.. (2018). Optimizing huddle engagement through leadership and problem-solving within primary care: A study protocol for a cluster randomized trial. Trials. 19(1). 536–536. 14 indexed citations

20.

Giblon, Rachel & Greta R. Bauer. (2017). Health care availability, quality, and unmet need: a comparison of transgender and cisgender residents of Ontario, Canada. BMC Health Services Research. 17(1). 283–283. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact